TY - JOUR
T1 - Single-dose oral lacosamide in refractory simple partial status epilepticus
T2 - Case report and review
AU - Hawkes, Maximiliano A.
AU - Fernández Suárez, Marcos
AU - Ugarnes, Gabriela
AU - D'Giano, Carlos
N1 - Copyright:
Copyright 2013 Elsevier B.V., All rights reserved.
PY - 2013/7
Y1 - 2013/7
N2 - OBJECTIVES: This study aimed to present 2 patients with simple partial refractory status epilepticus (RSE) treated with a single oral lacosamide (LCM) dose and to review the literature on this topic. METHOD: A retrospective description of 2 patients with simple partial RSE treated with 300 mg of LCM per os (PO) and a literature review were done. RESULTS: Both patients responded to single-dose oral LCM treatment with seizure cessation after 30 minutes. CONCLUSIONS: This is the first report on successful treatment of simple partial RSE with a single-dose of LCM PO. Oral LCM might represent an option for treatment of patients presenting with simple partial RSE.
AB - OBJECTIVES: This study aimed to present 2 patients with simple partial refractory status epilepticus (RSE) treated with a single oral lacosamide (LCM) dose and to review the literature on this topic. METHOD: A retrospective description of 2 patients with simple partial RSE treated with 300 mg of LCM per os (PO) and a literature review were done. RESULTS: Both patients responded to single-dose oral LCM treatment with seizure cessation after 30 minutes. CONCLUSIONS: This is the first report on successful treatment of simple partial RSE with a single-dose of LCM PO. Oral LCM might represent an option for treatment of patients presenting with simple partial RSE.
KW - Focal status epilepticus
KW - Lacosamide
KW - Refractory status epilepticus
KW - Simple partial status epilepticus
UR - http://www.scopus.com/inward/record.url?scp=84880840671&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880840671&partnerID=8YFLogxK
U2 - 10.1097/WNF.0b013e31829b21ba
DO - 10.1097/WNF.0b013e31829b21ba
M3 - Review article
C2 - 23860347
AN - SCOPUS:84880840671
SN - 0362-5664
VL - 36
SP - 138
EP - 140
JO - Clinical Neuropharmacology
JF - Clinical Neuropharmacology
IS - 4
ER -